These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24369293)

  • 21. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Le Noc P; Robert J; Le Noc D
    Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil.
    Fonseca EL; Vieira VV; Cipriano R; Vicente AC
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):303-9. PubMed ID: 15907453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang, China.
    Chen J; Su Z; Liu Y; Wang S; Dai X; Li Y; Peng S; Shao Q; Zhang H; Wen P; Yu J; Huang X; Xu H
    Int J Infect Dis; 2009 Nov; 13(6):717-21. PubMed ID: 19208492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Discovery of new structure of class 1 integron in MDR Pseudomonas aeruginosa and its association with drug-resistance].
    Zhu Y; Yi Y; Yang X; Lv N; Li J; Zhu B; Hu Y
    Wei Sheng Wu Xue Bao; 2013 Sep; 53(9):927-32. PubMed ID: 24377244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of integrons and antimicrobial resistance genes among Salmonella enterica from Brazil.
    Peirano G; Agersø Y; Aarestrup FM; dos Reis EM; dos Prazeres Rodrigues D
    J Antimicrob Chemother; 2006 Aug; 58(2):305-9. PubMed ID: 16782743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003).
    Sánchez-Romero I; Cercenado E; Cuevas O; García-Escribano N; García-Martínez J; Bouza E;
    Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ; Hsueh PR; Lu JJ; Chang FY; Ko WC; Wu JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):530-6. PubMed ID: 16816399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of integrons and tetracycline resistance determinants in Aeromonas spp. isolated from South African aquaculture systems.
    Jacobs L; Chenia HY
    Int J Food Microbiol; 2007 Mar; 114(3):295-306. PubMed ID: 17173998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF; El-Domany RA; Zaki S; Ashour HM
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance and Caco-2 cell invasion of Pseudomonas aeruginosa isolates from farm environments and retail products.
    Kim SH; Wei CI
    Int J Food Microbiol; 2007 Apr; 115(3):356-63. PubMed ID: 17289197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water.
    Silva ME; Filho IC; Endo EH; Nakamura CV; Ueda-Nakamura T; Filho BP
    Antonie Van Leeuwenhoek; 2008 May; 93(4):323-34. PubMed ID: 18038252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006).
    Yoo J; Sohn ES; Chung GT; Lee EH; Lee KR; Park YK; Lee YS
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased aztreonam susceptibility among Pseudomonas aeruginosa isolates from hospital effluent treatment system and clinical samples.
    Santoro DO; Romão CM; Clementino MM
    Int J Environ Health Res; 2012; 22(6):560-70. PubMed ID: 22540159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
    Drissi M; Ahmed ZB; Dehecq B; Bakour R; Plésiat P; Hocquet D
    Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Pseudomonas aeruginosa isolates collected from river water in Japan to antipseudomonal agents.
    Suzuki Y; Kajii S; Nishiyama M; Iguchi A
    Sci Total Environ; 2013 Apr; 450-451():148-54. PubMed ID: 23474260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
    Japoni A; Alborzi A; Kalani M; Nasiri J; Hayati M; Farshad S
    Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
    Poirel L; Brinas L; Fortineau N; Nordmann P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3593-7. PubMed ID: 16048994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.